Harvard Bioscience CFO Michael Rossi resigns; Jennifer Cote named interim CFO

HARVARD BIOSCIENCE INC

Michael Rossi resigns as CFO and Treasurer effective Dec 31, 2022; will provide transition assistance through May 10, 2023.
Jennifer Cote, VP of Global Finance since May 2022, appointed Interim CFO and Treasurer effective upon Rossi's departure.
Cote previously held finance leadership roles at Bose Corporation and Arthur Andersen; is a CPA and CGMA.
Company has initiated a search for a permanent CFO to succeed Rossi.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Jennifer Cote

Interim Chief Financial Officer and Treasurer

HBIO · HARVARD BIOSCIENCE INC

Effective: 2022-12-31
Filed: December 12, 2022, 6:59 PM ET

On December 8, 2022, the Company appointed Jennifer Cote to serve as Interim Chief Financial Officer and Treasurer effective upon Mr. Rossi’s resignation.

Departed

Michael Rossi

Chief Financial Officer and Treasurer

HBIO · HARVARD BIOSCIENCE INC

Effective: 2022-12-31
Successor: Jennifer Cote
Filed: December 12, 2022, 6:59 PM ET

On December 7, 2022, Michael Rossi notified Harvard Bioscience, Inc. (the “Company”) of his resignation as Chief Financial Officer and Treasurer, effective December 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jennifer Cote was appointed as Interim Chief Financial Officer and Treasurer at HARVARD BIOSCIENCE INC.

Action: appointed
Role: Interim Chief Financial Officer and Treasurer

Exact text from the filing

On December 8, 2022, the Company appointed Jennifer Cote to serve as Interim Chief Financial Officer and Treasurer effective upon Mr. Rossi’s resignation.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Rossi resigned as Chief Financial Officer and Treasurer at HARVARD BIOSCIENCE INC.

Action: resigned
Role: Chief Financial Officer and Treasurer

Exact text from the filing

On December 7, 2022, Michael Rossi notified Harvard Bioscience, Inc. (the “Company”) of his resignation as Chief Financial Officer and Treasurer, effective December 31, 2022.

View on SEC.gov

HARVARD BIOSCIENCE INC filing history →

Source: SEC EDGAR

accession 0001171843-22-007975

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.